Compliance with life sciences accounting standards has never been a simple task, but a new report by Deloitte says that public business entities in the life sciences must be aware of the impact of tax reform and recent changes to reporting standards for revenues associated with several activities if they want to maximize profits and stay out of the crosshairs of federal regulators.